Min Wei, Ph.D. is a senior advisor to Chief Business Executive and is a 20-year veteran of the drug discovery industry. Dr. Wei joined BeiGene at the start of the company as one of the key scientists and served as Head of Molecular Sciences prior to her current role. Dr. Wei was instrumental in the development of BeiGene’s early pipelines. Before joining BeiGene, Dr. Wei established and led the lab of Biochemistry and high throughput screening at BioDuro. In her prior positions, Dr. Wei was a research investigator and team leader at Incyte and GSK and contributed to numerous discovery programs in cancer, inflammation, cardiovascular diseases. She received her BS in chemistry from Tsinghua University, her PhD in Biochemistry from University of New Mexico and her post-doctoral training at MIT.